Jundishapur Journal of Microbiology

Published by: Kowsar

Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran

Mohammadreza Mahzounieh 1 , * , Mohammadreza Ghorani 2 , Ali Karimi 3 , Batoul Pourgheysari 4 and Razieh Nikoozad 5
Authors Information
1 Pathobiology Department, Research Institute of Zoonotic Diseases, Shahrekord University, Shahrekord, IR Iran
2 Department of Microbiology, Tehran University, Tehran, IR Iran
3 Microbiology and Immunology Department, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
4 Pathology and Hematology Department, Shahrekord University of Medical Sciences, Shahrekord, IR Iran
5 Department of Microbiology, Islamic Azad University, Falavarjan Branch, Falavarjan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: June 01, 2015, 8 (6); e17201
  • Published Online: June 27, 2015
  • Article Type: Research Article
  • Received: December 27, 2013
  • Revised: May 18, 2014
  • Accepted: June 2, 2014
  • DOI: 10.5812/jjm.8(5)2015.17201

To Cite: Mahzounieh M, Ghorani M, Karimi A, Pourgheysari B, Nikoozad R. Prevalence of Human T-Lymphotropic Virus Types I and II in Patients With Hematological Disorders in Isfahan, Iran, Jundishapur J Microbiol. 2015 ; 8(6):e17201. doi: 10.5812/jjm.8(5)2015.17201.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980; 77(12): 7415-9[PubMed]
  • 2. Kalyanaraman VS, Sarngadharan MG, Poiesz B, Ruscetti FW, Gallo RC. Immunological properties of a type C retrovirus isolated from cultured human T-lymphoma cells and comparison to other mammalian retroviruses. J Virol. 1981; 38(3): 906-15[PubMed]
  • 3. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007; 7(4): 270-80[DOI][PubMed]
  • 4. Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int J Exp Pathol. 2001; 82(3): 135-47[PubMed]
  • 5. Monplaisir N, Neisson-Vernant C, Bouillot M, Duc-Dodon M, Ugarte E, Valette I, et al. HTLV-I maternal transmission in Martinique, using serology and polymerase chain reaction. AIDS Res Hum Retroviruses. 1993; 9(9): 869-74[PubMed]
  • 6. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1989; 111(7): 555-60[PubMed]
  • 7. Rafatpanah H, Farid R, Golanbar G, Azad FJ. HTLV-I Infection: virus structure, immune response to the virus and genetic association studies in HTLV-I-infected individuals. Iran J Allergy Asthma Immunol. 2006; 5(4): 153-66
  • 8. Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992; 51(6): 886-91[PubMed]
  • 9. Ghaffari J, Kowsarian M, Mahdavi M, Vahid Shahi K, Rafatpanah H, Tafreshian A. Prevalence of HTLV-I Infection in Patients with Thalassemia Major in Mazandaran, North of Iran. Jundishapur J Microbiol. 2012; 6(1): 57-60[DOI]
  • 10. Inoue H, Matsushita K, Arima N, Hamada H, Uozumi K, Ozaki A, et al. High prevalence of human T-lymphotropic virus type I carriers among patients with myelodysplastic syndrome refractory anemia with excess of blasts (RAEB), RAEB in transformation and acute promyelocytic leukemia. Leuk Lymphoma. 2008; 49(2): 315-21[DOI][PubMed]
  • 11. Starkebaum G, Loughran TJ, Kalyanaraman VS, Kadin ME, Kidd PG, Singer JW, et al. Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet. 1987; 1(8533): 596-9[PubMed]
  • 12. Adedayo OA, Shehu SM. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: a seroprevalence study. Am J Hematol. 2004; 77(4): 336-9[DOI][PubMed]
  • 13. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005; 24(39): 6058-68[DOI][PubMed]
  • 14. Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009; 41(5): 498-9[PubMed]
  • 15. Azarpazjhoo M, Hasanpoor K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati Moghaddam M. HTLV-I prevalence in Northeastern Iran, Sabzevar; An epidemiologic based study and phylogenetic analysis. AIDS Res Hum Retrovir. 2012; 28(9): 1095-101
  • 16. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011; 52(3): 172-6[DOI][PubMed]
  • 17. Karimi A, Nafici M, Imani R. Comparison of human T-cell leukemia virus type-1 (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari Province, Iran. Kuwait Med J. 2007; 39(3): 259-61
  • 18. Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008; 19(5): 838-41[PubMed]
  • 19. Dehée A, Césaire R, Désiré N, Lézin A, Bourdonné O, Béra O, et al. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods. 2002; 102(1): 37-51
  • 20. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997; 15: 15-37[DOI][PubMed]
  • 21. Dougan S, Payne LJ, Tosswill JH, Davison K, Evans BG. HTLV infection in England and Wales in 2002--results from an enhanced national surveillance system. Commun Dis Public Health. 2004; 7(3): 207-11[PubMed]
  • 22. Payne LJ, Tosswill JH, Taylor GP, Zuckerman M, Simms I. In the shadow of HIV-HTLV infection in England and Wales, 1987-2001. Commun Dis Public Health. 2004; 7(3): 200-6[PubMed]
  • 23. Chiewsilp P, Iamsilp W, Hathirat P. HTLV-I antibody screening in donated blood and thalassemic patients. J Med Assoc Thai. 1993; 76 Suppl 2: 103-5[PubMed]
  • 24. Covas DT, Boturao Neto E, Zago MA. The frequency of blood-born viral infections in a population of multitransfused Brazilian patients. Rev Inst Med Trop Sao Paulo. 1993; 35(3): 271-3[PubMed]
  • 25. Farias de Carvalho SM, Pombo de Oliveira MS, Thuler LC, Rios M, Coelho RC, Rubim LC, et al. HTLV-I and HTLV-II infections in hematologic disorder patients, cancer patients, and healthy individuals from Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 15(3): 238-42[PubMed]
  • 26. Miyagi J, Toda T, Uezato H, Ohshima K, Miyakuni T, Takasu N, et al. Detection of Epstein-Barr virus and human T-cell lymphotropic virus type 1 in malignant nodal lymphoma, studied in Okinawa, a subtropical area in Japan. Int J Hematol. 2002; 75(1): 78-84[PubMed]
  • 27. Barrientos A, Lopez M, Sotomayor C, Pilleux L, Calderon S, Navarrete M, et al. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile. J Med Virol. 2011; 83(4): 745-8[DOI][PubMed]
  • 28. Monavari SH, Keyvani H, Salehi Vaziri M, Bokharaei Salim F. Detection of human T-cell lymphotropic virus Type-1 among patients with malignant hematological diseases in Capital of Iran, Tehran. J General Mol Virol. 2011; 3(5): 67-70
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments